Analysts/Institutional Investor Meet/Con. Call Updates

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 30th July 2026 BSE LIMITED National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. Dalal Street, C/1, G Block, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub: Audio recording of Earnings call conducted on 30th July 2026 Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 30th July 2026 at 4.15 p.m. has been uploaded on the Company’s website and can be accessed through the link: https://www.ajantapharma.com/assets/frontend/images/investors/files/quarterly_results/ 1785412661_Earnings-Audio-Q1-FY2027.mp3 Written transcript of the same will be submitted in due course. This is for your information and records please. Yours faithfully, GAURANG SHAH Sr. VP – Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059